Commentary by Dr Michael Spartalis

Commentary by Dr Dorien Kimenai

Commentary by Dr Dennis W.T. Nilsen

Commentary by Dr Cheol Hyun Lee

Commentary by Dr Jung-Sun Kim

Commentary by Dr Song-Young Park

Commentary by Dr Kevin Ka-Ho Kam

Commentary by Dr. Emile Daoud

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Drs. Julia Grapsa, Mohammad Kassar, Edoardo Zancanaro, and Hooman Bakhshi.

Commentary by Dr. Julia Grapsa

Raúl Córdoba, MD, PhD, discusses cardiotoxicities of treatments for hematological malignancies, the importance of geriatric hematology, and his views on the STOP-CA trial. Moderated by Sarah Waliany, MD, MS.

Carmen Bergom, MD, PhD, Alicia Morgans, MD, MPH, and June-Wha Rhee, MD discuss their experiences as women with careers in cardio-oncology, the importance of mentorship and sponsorship, rewards and challenges of building research careers, striking a balance with personal and family lives, negotiation strategies to address pay disparities, and institutional policies needed to advance the careers of women. Moderated by Sarah Waliany, MD, MS.

Erin Aakhus, MD, MSHP, Dipti Gupta, MD, MPH and Eric Yang, MD, FACC share their perspectives as fellowship Program Directors or Associate Program Directors on the process of applying for fellowship in cardiology, hematology/oncology, or cardio-oncology and how applicants can stand out as applicants. Moderated by Sarah Waliany, MD, MS.